Loading...
Please wait, while we are loading the content...
Sudden Cardiac Death in Young Athletes
| Content Provider | Semantic Scholar |
|---|---|
| Author | Patel, Dilip R. |
| Copyright Year | 2011 |
| Abstract | he article by Halabchi et al. provides a comprehensive, thoughtful and balanced analysis of the literature on sudden cardiac death (SCD) in young athletes [1]. The article is unique in providing a special perspective for Asia as contrasted with those in Europe and the United States. This aspect is extremely important to recognize for the management of young athletes in different parts of the world. In the United States, the history and physical examination (H&P) has been the standard of cardiovascular screening for competitive athletes, although several studies have questioned the efficacy of the screening H&P alone in identifying athletes at risk for cardiovascular adverse events [2-6]. The H&P has come under scrutiny for having low sensitivity for identifying athletes with cardiovascular risk factors. Several studies have reported data substantiating the higher efficacy of electrocardiogram (ECG) in identifying athletes with hypertrophic cardiomyopathy (HCM), channelopathies, and other clinically silent cardiovascular diseases that increase the risk for SCD in young athletes [2,6-12]. The Italian experience using the ECG as part of screening athletes is cited most frequently as the basis for including ECG as a screening tool [4]. One argument against that study is that it is an observational study and not a prospective study with a control population [3]. At present there is no worldwide consensus on the added value of including ECG as a screening tool for all young athletes. In the United States the American Heart Association report provides the general framework for cardiovascular screening [3,5]. Large prospective studies are needed to evaluate the value of screening ECGs in the US population. 2-D echocardiogram (ECHO) is most useful for the diagnosis of structural heart disease [13]. Adding an ECHO to a cardiovascular screening program increases the likelihood of identifying structural abnormalities of the heart. The added cost of screening and the scarcity of resources, equipment, and personnel are significant barriers to recommend routine use of ECHO for screening. An ECHO can be considered a good confirmatory test after abnormal findings on H&P or ECG. There have been significant advances in the identification of genetic causes for cardiovascular diseases, leading to the question of present or future methods involving identification of genetic risk factors for cardiovascular disease using genetic testing as a screening tool [14,15]. Exercise stress testing is of limited value as a screening tool but has a role in risk strat-ification [13]. Exercise stress testing has been recommended … |
| Starting Page | 120 |
| Ending Page | 122 |
| Page Count | 3 |
| File Format | PDF HTM / HTML |
| PubMed reference number | 22375228v1 |
| Volume Number | 2 |
| Journal | Asian journal of sports medicine |
| Alternate Webpage(s) | http://asjsm.com/50476.pdf |
| Alternate Webpage(s) | http://asjsm.tums.ac.ir/index.php/asjsm/article/download/43/43 |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Adverse event Athletes |
| Content Type | Text |
| Resource Type | Article |
